| AMAG Revs Miss; Maintains 2011 View - Zacks.com |
|
|
Zacks.com Sales of Feraheme were down 28% sequentially to $10.9 million from $15.2 million in the prior quarter due to decline in provider demand particularly from the dialysis segment. Total Feraheme provider demand and launch incentive program utilization was |